Bimatoprost Implant (Ripple Therapeutics)

贝美前列素植入物 (Ripple Therapeutics)

Report date: 2026/01/04 17:56:04

Base Information

Drug NameBimatoprost Implant (Ripple Therapeutics)
Drug Alias NameRTC-620RTC-620 ICRTC-620 IVT
ClassificationSmall molecules
Mechanisms of ActionProstanoid receptor agonists
TargetsProstanoid receptor
Therapy Area/IndicationsGlaucoma, Open-AngleOcular Hypertension
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesRipple Therapeutics Corp
China Registration ClassN/A

Develop Information

Active CompaniesRipple Therapeutics CorpAbbvie Inc
Inactive CompaniesN/A
Active IndicationsGlaucoma, Open-AngleOcular Hypertension
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A